Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Bydureon

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
The Bydureon® BCise® pre-filled pen was developed largely to simplify self-administration of exenatide extended-release for… Expand
Is this relevant?
2019
2019
The time-dependent (30 min - day 84) plasma profile of PT320, a sustained-release (SR)-Exenatide formulation under clinical… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
2016
2016
Pluronic F127 and PEG as a multi-gel-core were used to prepare Exenatide-loaded microspheres and store the drug within the… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Review
2014
Review
2014
Type 2 diabetes is still rapidly on the rise today, affecting 10.5% of individuals in the United States between the ages 45 to 64… Expand
Is this relevant?
2014
2014
Bydureon is a new galenic formulation (long-acting release) of exenatide, the first agonist of Glucagon-Like Peptide-1 (GLP-1… Expand
Is this relevant?
2014
2014
®est une nouvelle forme galenique, a liberation prolongee, de l’exenatide, premier agoniste des recepteurs du Glucagon-Like… Expand
  • figure 1
Is this relevant?
2013
2013
Glucagon-like peptide (GLP)-1 agonists are one of the newer classes of medications for use in type 2 diabetes. There are… Expand
  • table 1
  • table 2
Is this relevant?
2012
2012
Bydureon is a long-acting formulation of exenatide administered as a once-weekly injection. The authors present the clinical data… Expand
Is this relevant?
2012
2012
  • Amylin Pharmaceuticals
  • 2012
  • Corpus ID: 27422449
Mechanism of Action: 1,2,3,4, : Incretins, such as glucagon-like peptide-1 (GLP-1), enhance glucose-dependent insulin secretion… Expand
  • table 1
Is this relevant?
2011
2011
for patients with severe renal impairment or end-stage renal disease. It should be used with caution in renal transplant… Expand
  • table 1
Is this relevant?